FABTECH vs VAISHALI: Stock Comparison

Fabtech Technologies Limited vs Vaishali Pharma LtdUpdated 25 Aug 26, 4:08 PM ISTNSE & company filings

Fabtech Technologies Limited is the larger company by market capitalisation. Fabtech Technologies Limited shows a higher ROE, a higher dividend yield and lower leverage, while Vaishali Pharma Ltd shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

FABTECH leads 7; VAISHALI leads 1 of 8

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

FABTECHVAISHALI

Valuation lens

What price are you paying?

Market CapContext only
₹659 Cr
₹105 Cr
P/E RatioSame reading
13.38x
P/B RatioSame reading
1.55x
EPSFABTECH has the higher reading
₹10.95
₹0.32
Book ValueContext only
₹109.44
₹5.3
Dividend YieldFABTECH has the higher reading
0.41%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
FABTECH is the larger company
₹659 Cr vs ₹105 Cr
EPS
FABTECH has higher earnings per share
₹10.95 vs ₹0.32
Dividend Yield
FABTECH has a higher dividend yield
0.41% vs 0%
Revenue Growth (TTM YoY)
VAISHALI has faster revenue growth
18.35% vs 17.5%
EPS Growth (TTM YoY)
FABTECH has faster EPS growth
23.4% vs -76.71%
ROE
FABTECH has a higher ROE
12.5% vs 6.02%
Net Margin
FABTECH has a higher net margin
11.28% vs 3.83%
Operating Margin
FABTECH has a higher operating margin
8.52% vs 3.78%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFABTECHVAISHALI
SectorHealthcareHealthcare
IndustryMedical Equipment & SuppliesPharmaceuticals

Price

MetricFABTECHVAISHALI
Live Price₹147.62₹7.97
Day Change0.39%-1.85%
Volume1.64 L93,607
52-Week High₹262.8₹12.75
52-Week Low₹132.7₹4.75
Distance from 52W High-43.83%-37.49%

Valuation

MetricFABTECHVAISHALI
Market Cap₹659 Cr₹105 Cr
P/E Ratio13.38x
P/B Ratio1.55x
EPS₹10.95₹0.32
Book Value₹109.44₹5.3
Dividend Yield0.41%0%

Growth

MetricFABTECHVAISHALI
Revenue Growth (TTM YoY)17.5%18.35%
EPS Growth (TTM YoY)23.4%-76.71%
Qtr Sales Growth17.5%
Qtr Profit Growth46.2%

Profitability & Leverage

MetricFABTECHVAISHALI
ROE12.5%6.02%
ROCE13.6%
Net Margin11.28%3.83%
Operating Margin8.52%3.78%
Debt to Equity0.17x0.27x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFABTECHVAISHALI
Promoter Holding68.94%31.61%
FII Holding0.02% 0.06 pp0%
DII Holding2.45% 0.3 pp0%
Public Holding28.58% 0.25 pp68.39%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Fabtech Technologies Limited and Vaishali Pharma Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.